Biotech Stars And Startups Raise $168m In Venture Cash
This article was originally published in Scrip
Executive Summary
Drug developers continue to raise significant venture capital in 2015 with experienced executives and novel therapeutic approaches attracting large VC funding rounds to support early-stage research and development programs, including a $40m Series C round for True North Therapeutics.